共 51 条
[1]
Biberthaler P(2018)Versorgungsforschung Unfallchirurg 121 938-939
[2]
Bonnaire F(2019)Management vorbestehender Antikoagulation zur zeitgerechten Versorgung von hüftnahen Frakturen Unfallchirurg 122 404-410
[3]
Bula P(2014)Effectiveness of vitamin K in anticoagulation reversal for hip fracture surgery—a prospective observational study Thromb Res 133 42-47
[4]
Schellong S(2016)Andexanet alfa for acute major bleeding associated with factor Xa inhibitors N Engl J Med 375 1131-1141
[5]
Buecking B(2018)Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants Thromb Res 166 106-112
[6]
Eschbach D(2017)Abstract 20205: the impact of Andexanet alfa in a porcine polytrauma model under apixaban anticoagulation: investigation of hemostatic safety and efficacy Circulation 136 A20205-A20205
[7]
Bliemel C(2015)Idarucizumab, a specific dabigatran reversal agent, reduces blood loss in a porcine model of trauma with dabigatran anticoagulation J Am Coll Cardiol 66 1518-1519
[8]
Connolly SJ(2018)Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA Drugs Ther Perspect 34 507-512
[9]
Milling TJ(2017)Immediate versus delayed surgery for hip fractures in the elderly patients: a protocol for a systematic review and meta-analysis Syst Rev 6 164-207
[10]
Eikelboom JW(2019)Surgical delay is not warranted for patients with hip fractures receiving non-warfarin anticoagulants Orthopedics. 19 203-794